News Releases


Journal of Urology publishes University of Washington First-In-Human clinical trial results from the first 19 subjects treated by BWL. Article selected for the cover of the May edition (press release).


SonoMotion treats its 40th subject in the Break Wave Feasibility First-In-Human clinical trial.


SonoMotion secures a $400,000 Commercial Readiness Program (CRP) SBIR grant from the NIH.


SonoMotion closes $10M Series-B round co-led by Advance MedTech Holdings Pte. Ltd., MedVenture Partners Inc and BioVentures. Link to press release.


SonoMotion initiates First-In-Human clinical trial of its Break Wave™ stone fragmentation system.


SonoMotion secures a $3M SBIR Phase IIB grant from the NIH in support of its Break Wave™ First-In-Human clinical trial. Planned sites include UW, UBC, UCSD, Cleveland Clinic and Chesapeake Urology.


GE Healthcare and SonoMotion sign a second co-development agreement and expand their strategic relationship with an updated OEM agreement.


SonoMotion receives Health Canada ITA approval to initiate its Break Wave™ First-In-Human clinical trial in Canada.